Bicycle Therapeutics
The Director - Senior Director, Statistical Programming provides strategic and technical leadership for the statistical programming function, ensuring the delivery of high-quality data and analysis for the company's clinical portfolio. This role involves driving operational excellence, managing CROs and vendors, and leading a team of programmers to support clinical trials and regulatory submissions. The position serves as a key strategic partner to Biostatistics and Clinical Development while maintaining compliance with regulatory standards.
Headquarters
Great Abington, England, United Kingdom
Company Size
201-500 employees
Founded
2009
Bicycle Therapeutics is a clinical-stage biopharmaceutical company that pioneers a proprietary "Bicycle" bicyclic peptide platform to create precision-guided therapeutics. Their modular, constrained peptides are engineered to bind targets with high affinity and can be formatted as multispecific agents or linked to payloads (e.g., cytotoxins or immune modulators) to enable targeted delivery, with a strong focus on oncology and other serious diseases. The company emphasizes rapid tissue penetration, scalable chemistry and strategic collaborations to advance a pipeline of targeted therapies toward clinical development.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Bicycle Therapeutics.
8% above the average for this role
Associate Director, Statistical Programming
kaileratherapeutics
Associate Director, Statistical Programming
Tango Therapeutics
Manager, Statistical Programming
Celcuity
Director of Statistical Programming
Summit Therapeutics,
Director, Statistical Programming
CSL Behring Australia
Associate Director, Statistical Programming
Nuvalent, Inc.